TRANSENTERIX INC - COM NEW (TRXC)

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM NEW
Total 13F shares
35,942,904
Share change
-5,067,951
Total reported value
$152,770,000
Put/Call ratio
28%
Price per share
$4.25
Number of holders
75
Value change
-$14,006,145
Number of buys
51
Number of sells
21

Institutional Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q1 2016

As of 31 Mar 2016, TRANSENTERIX INC - COM NEW (TRXC) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,942,904 shares. The largest 10 holders included Aisling Capital LLC, SV Life Sciences Advisers, LLC, StepStone Group LP, JPMORGAN CHASE & CO, MASTERS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, and GOLDMAN SACHS GROUP INC. This page lists 75 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.